Shengsheng Zhou

No.6 Shuangyong Road
Nanning, 530021, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

A deep learning-based prognostic model for diffuse large B-cell lymphoma incorporating PET/CT imaging features.

A deep learning-based prognostic model for diffuse large B-cell lymphoma incorporating PET/CT imaging features.

Journal: Frontiers in oncology
Published: April 08, 2026

Clinical characteristics, treatment patterns, and survival outcomes of 1031 patients with peripheral T cell lymphoma in china: a multicenter, real-world study.

Clinical characteristics, treatment patterns, and survival outcomes of 1031 patients with peripheral T cell lymphoma in china: a multicenter, real-world study.

Journal: Discover oncology
Published: February 13, 2025

Efficacy of brentuximab vedotin combined with sintilimab in relapsed/refractory DLBCL patient with secondary hemophagocytic syndrome: a case report and literature review.

Efficacy of brentuximab vedotin combined with sintilimab in relapsed/refractory DLBCL patient with secondary hemophagocytic syndrome: a case report and literature review.

Journal: Frontiers in oncology
Published: November 20, 2024

Correction to: Efficacy and safety of trifluridine/tipiracil (TAS‑102) in patients with metastatic colorectal cancer: a systematic review and meta‑analysis.

Correction to: Efficacy and safety of trifluridine/tipiracil (TAS‑102) in patients with metastatic colorectal cancer: a systematic review and meta‑analysis.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: August 03, 2023

Efficacy and safety of trifluridine/tipiracil (TAS-102) in patients with metastatic colorectal cancer: a systematic review and meta-analysis.

Efficacy and safety of trifluridine/tipiracil (TAS-102) in patients with metastatic colorectal cancer: a systematic review and meta-analysis.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: May 22, 2023

Deoxythymidylate kinase (DTYMK) participates in cell cycle arrest to promote pancreatic adenocarcinoma progression regulated by miR-491-5p through TP53 and is associated with tumor immune infiltration.

Deoxythymidylate kinase (DTYMK) participates in cell cycle arrest to promote pancreatic adenocarcinoma progression regulated by miR-491-5p through TP53 and is associated with tumor immune infiltration.

Journal: Journal of gastrointestinal oncology
Published: May 06, 2023

The expression of Slit2 and Robo1 increased during retinoic acid syndrome in acute promyelocytic leukemia and impacted differentiated cell migration.

The expression of Slit2 and Robo1 increased during retinoic acid syndrome in acute promyelocytic leukemia and impacted differentiated cell migration.

Journal: Translational oncology
Published: December 09, 2021

SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation.

SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation.

Journal: Trials
Published: May 07, 2021
Showing 1-8 of 8

Last Updated: 09/26/2026